Cysteamine Bitartrate

CHEMBL1200577 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
227.2 g/mol
LogP
Phase
4

The bitartrate salt of cysteamine, used orally to treat nephropathic cystinosis by reducing intracellular cystine accumulation. The delayed-release bitartrate formulation improves tolerability compared to the immediate-release form.

الوزن الجزيئي

227,2400 g/mol

TPSA

142,00 Ų

المجالات العلاجية

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NCCS.O=C(O)[C@H](O)[C@@H](O)C(=O)O

InChI

InChI=1S/C4H6O6.C2H7NS/c5-1(3(7)8)2(6)4(9)10;3-1-2-4/h1-2,5-6H,(H,7,8)(H,9,10);4H,1-3H2/t1-,2-;/m1./s1

Molecular Formula

C6H13NO6S

HBD / HBA

6 / 8

الروابط القابلة للدوران

4

الذرات الثقيلة

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

The bitartrate salt of cysteamine, used orally to treat nephropathic cystinosis by reducing intracellular cystine accumulation. The delayed-release bitartrate formulation improves tolerability compared to the immediate-release form.

Yes, Cysteamine Bitartrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200577. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 11958147. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.